Evaluation of efficacy and safety of Aujeszky's disease vaccines

• Autorzy: Lipowski A.
• Języki publikacji: EN

Abstrakty

EN

Since Aujeszky's disease have become an economic problem in pig farms in late 1960's and early 1970's many different vaccines, either inactivated or live - attenuated were developed. Soon it became evident that they differ in their efficacy. In this article a panel of tests used for evaluation of safety and efficacy of inactivated as well as live Aujeszky's disease vaccines is described.

Słowa kluczowe

EN

Aujeszky's disease; veterinary medicine; vaccine; efficacy; safety; pig farm

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2006
• Tom: 09
• Numer: 1
• Opis fizyczny: p.75-79,ref.

Twórcy

autor

Lipowski A.

• National Veterinary Research Institute, Partyzantow 57, 24-100 Pulawy, Poland

Bibliografia

• De Lceuw PW, van Oirschot JT (1985) Vaccines against Aujeszky’s disease: evaluation of their efficacy under standardized laboratory conditions. Vet Quart 7:191-197.
• European Pharmacopoeia (1997) Monograph 0744: Aujeszky’s disease vaccine (inactivated) for pigs (Vac- cinum morbi Aujeszkyi ad suem inactivatum), Mono­graph 0745: Aujeszky’s disease vaccine (live) for pigs for parenteral administration, freeze-dried (Vaccinum morbi Aujeszkyi ad suem vivum cryodesiccatum ad usum paren- terale). 3rd ed., Council of Europe, Strasbourg, France, pp 420-424.
• Kit S. (1989) Safety and efficacy of genetically engineered Aujeszky’s disease vaccines. Curr Top Vet Med Anim Sci 49: 45-55.
• Kluge JP, Beran GW, Hill HT, Platt KB (1999) Pseudorabies (Aujeszky’s disease). In: Straw BE et al (ed) Diseases of swine. 8th ed., Iowa State University Press, Ames, Iowa, pp 233-246.
• Lipowski A. (1995) Efficacy evaluation of PR-Vac Plus™ vaccine against Aujeszky’s disease virus infection. Proc 2nd Int Symp Eradication of Aujeszky’s Disease (Pseudorabies) Virus, Copenhagen, Denmark, p 11.
• Marchioli CC, Yancey RJ, Wardley RC, Thomsen DR, Post LE (1987) A vaccine strain of pseudorabies virus with deletions in the thymidine kinese and glycoprotein X genes. Am J Vet Res 48: 1577-1583.
• Martin S., Wardley RC (1986) Evaluation of immunity to Aujeszky’s disease virus. Rev sci tech Off int Epiz 5: 379-387.
• Mikulska-Skupieh E, Szweda W, Procajlo Z (2005) Evalu­ation of efficacy of pig vaccination using deleted vaccine against Aujeszky’s disease. Med Weter 61: 58-62.
• Molitor TW, Hill HT (1988) Safety, efficacy and field stu­dies with syntrovet pseudorabies vaccine, prv/marker. Proc Am Assoc Swine Pract, 6-8 March, St. Luis, pp 75-78.
• Pejsak Z, Lipowski A, Baars J (1990) Comparative study of the efficacy of a deleted and a traditionally attenuated vaccine against Aujeszky’s disease (AD). Proc 11th IPVS Congr, Lausanne, Switzerland, p 245.
• Stellmann C, Vannier P, Chappuis G, Brun A, Dauvergne M, Fargeaud D, Bugand M, Colson X (1989) The po­tency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement. J Biol Stand 17: 17-27.
• Szweda W (1992) Studies on application of various methods of Aujeszky’s disease prophylaxis and eradication in pigs. Acta Acad Agricult tech Olst Veterinaria 20, Suppl. A, pp 1-59.
• Van Oirschot JT (1987) Intranasal vaccination of pigs against Aujeszky’s disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres. Res Vet Sei 42: 12-16.
• Van Oirschot JT, Gielkens ALJ, Moormann RJM, Berns AJM (1990) Marker vaccines, virus protein-specific anti­body assays and the control of Aujeszky’s disease. Vet Microbiol 23: 85-101.
• Visser N, Lütticken D (1988) Experiences with a gl/TK' modified live pseudorabies virus vaccine: strain Begonia. Curr Top Vet Med Anim Sei 49: 37-44.
• Wittmann G (1979) Schutzimpfung gegen Aujeszkysche Krankheit (AK) mit inaktivierten Vakzinen. Dtsch Tierarztl Wochenschr 86: 316-322.
• Wittmann G (1982) Can Aujeszky’s disease be controlled by vaccination? Tierärztliche Umschau 37: 535-538.
• Wittmann G (1986) Live Aujeszky’s disease vaccines. Tierär­ztliche Umschau 41: 641-652.